ARNA Financial Facts

Cost of manufacturing services: 81K
Gain from valuation of derivative liabilities: 2.59M
See Full Income Statement

Total liabilities and stockholders' equity: 296.67M
Prepaid expenses and other current assets: 5.97M
See Full Balance Sheet

Arena Pharmaceuticals, Inc. (ARNA) Earnings

  |   Expand Research on ARNA
Next EPS Date 8/3/15 *Est. EPS Growth Rate +16.7% *Last Qtr.
Average EPS % Beat Rate +47.3% Revenue Growth Rate +80.9% *Last Qtr.
Average % Move 1-Wk after EPS -1.2% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/10 Q310 -$0.31-$0.23 -$0.08N/AN/A N/A Details
3/11/11 Q410 -$0.23-$0.21 -$0.02$4.01M$4.81M N/A Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A Details
8/9/11 Q211 -$0.16-$0.16 $0.00$3.26M$3.35M N/A Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A Details
5/11/15 Q115 -$0.10-$0.14 +$0.04$12.3M$10.56M N/A Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A Details
11/3/14 Q314 -$0.05-$0.12 +$0.07$8.2M$10.9M N/A Details